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Despite 40 years of research into evidence-based policy (EBP) and a continued drive from both policymakers and
researchers to increase research uptake in policy, barriers to the use of evidence are persistently identified in the
literature. However, it is not clear what explains this persistence – whether they represent real factors, or if they are
artefacts of approaches used to study EBP. Based on an updated review, this paper analyses this literature to explain
persistent barriers and facilitators. We critically describe the literature in terms of its theoretical underpinnings,
definitions of ‘evidence’, methods, and underlying assumptions of research in the field, and aim to illuminate the
EBP discourse by comparison with approaches from other fields. Much of the research in this area is theoretically
naive, focusing primarily on the uptake of research evidence as opposed to evidence defined more broadly, and
privileging academics’ research priorities over those of policymakers. Little empirical data analysing the processes or
impact of evidence use in policy is available to inform researchers or decision-makers. EBP research often assumes
that policymakers do not use evidence and that more evidence – meaning research evidence – use would benefit
policymakers and populations. We argue that these assumptions are unsupported, biasing much of EBP research.
The agenda of ‘getting evidence into policy’ has side-lined the empirical description and analysis of how research and
policy actually interact in vivo. Rather than asking how research evidence can be made more influential, academics
should aim to understand what influences and constitutes policy, and produce more critically and theoretically
informed studies of decision-making. We question the main assumptions made by EBP researchers, explore the
implications of doing so, and propose new directions for EBP research, and health policy.
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movement
Although sceptics can be found, few researchers or
policymakers would publicly disagree that evidence-based
policy (EBP) is a goal for both academe and government.
Reports describing the importance – and difficulty of –
achieving this goal are published with regularity [1-3].
Perhaps unlike other disciplines, EBP has staunch
advocates who contribute to an ever-increasing body
of commentary around the subject.
EBP is sometimes said to have derived from evidence-
based medicine (EBM), which dates back at least to 1972,
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unless otherwise stated.efficiency [4]. Since the early 1970s, both practitioners and
academics have also considered how policy – in the
sense of larger-scale decisions about the delivery and
management of services at a population level – could
be based on, or informed by, evidence [5,6]. For
Cochrane and his heirs, the goal of EBM was to bring
about the abandonment of harmful and ineffective
interventions, and the adoption of interventions shown to
be effective for clinical outcomes. This was to be achieved
by implementing findings from systematic reviews and
meta-analyses of robust outcome evaluations, ideally
randomised trials [7-10].
However, this straightforward narrative of evaluation-
based EBP modelled on medicine has long existed in a
broader landscape of initiatives to foster closer and more
effective links between research and policy (or between
researchers and policy-makers). In the UK, for example,
these ideas can be traced back at least to the Rothschildtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Oliver et al. Health Research Policy and Systems 2014, 12:34 Page 2 of 11
http://www.health-policy-systems.com/content/12/1/34experiment, evaluated by Kogan and Henkel in 1983
[11]. The aim of this funding initiative was to enable the
health research system to respond to policymakers’
priorities for research [12]. The experiment was
largely abandoned, which Kogan and Henkel ascribed to
cultural differences between researchers and policymakers,
the need for interaction, and other barriers [12,13]. Recent
publications, again in the UK, from the Government Office
for Science have provided guides for both academics and
policymakers who wish to engage with the other group
[14,15], and there is increasing interest within academic
and higher education bodies generally about how academics
may be able to increase their impact, the nature of this im-
pact, and implications of the ‘impact agenda’ [16-18].
However, the tenor of these publications still tends to
focus on promoting the use of academic research, rather
than studying the practices of knowledge production and
policymaking and implementation.
As a result, specific questions about the use of research
within policy have become divorced from a broader
perspective on policy-making. Many researchers in what
may be termed ‘applied research’ fields use terms like
‘knowledge translation’, ‘knowledge exchange’, or ‘evidence
use’ without providing clear definitions of what knowledge
is part of which decision-making process [19-21]. The
result has been a loss of clarity with respect to how
evidence is supposed to improve decision-making, what
constitutes and defines ‘evidence’ and ‘policy’, and which
processes and outcomes are targeted by political or
academic efforts. Nevertheless, both EBM and EBP have
achieved substantial financial and political support, and
substantial weight by the creation of a collection of
organisations dedicated to producing evidence-based
policy and practice recommendations, guidelines, and best
practice statements, such as the What Works centres [22].
For health policy and health management in particular,
there remains a prominent discourse about moral, ethical,
political, and often financial imperatives to use evidence
to make the best (value) decisions [23] – without, ideally,
disenfranchising non-expert publics [24]. The study of the
use of evidence in policy varies from negative to positive
advocacy, from simplistic to complex understandings
of the processes involved, from uncritical technical
approaches to highly cynical commentary. Broadly,
practitioners and academics have focused on facets of
the use of evidence by policymakers and practitioners,
have written polemics encouraging colleagues to do so
[23,25-29], identified barriers and facilitators into evidence
use [30,31], and designed interventions to increase the use
of evidence by policymakers [32]. Evidence-based policy
and practice, knowledge translation, and related concepts
have become touchstones across a vast range of disciplines
– almost sub-disciplines in their own right, with canons
and conceptual toolkits of their own.While much of this work remains mainly theoretical
(e.g., [33]), there is a rapidly growing empirical evidence
base on barriers and facilitators of evidence use. Some
idea of the extent and nature of this literature can be
gained by looking at systematic reviews. Three reviews
are particularly relevant here [30,31,34]; their methods,
findings, and conclusions are summarised in Table 1.
Common findings across all three include the im-
portance of personal relationships and contacts be-
tween decision-makers and researchers, and the need
for research to be clearly and accessibly presented. Cul-
tural and practical barriers to the use of evidence by
policy-makers are identified. Finally, all three make the
point that policymakers’ definitions of evidence do not
match academic constructions of ‘evidence’. All three
reviews also point to gaps in the literature as priorities for
further research, but differ in their identification of these
gaps. Orton focuses on the need for evaluation re-
search of strategies to increase the uptake of research
evidence [31], while Innvær et al. [34] and Oliver et al.
[30] are both more circumspect, pointing out that despite
the size of the evidence base, much about policy-makers’
attitudes to research evidence remains unclear. Innvær
et al. show how the limited available evidence mainly
describes policymakers’ beliefs and attitudes, rather
than actual behaviours, and hence cannot be used as a
basis to make strong recommendations [34]. Perhaps
more importantly, both reviews note that there are few
grounds by which to make firm recommendations or
conclusions about the process, impact, or effectiveness
of research in policy. Only rarely is enough detail
known about the policy process to be able to com-
ment usefully: for example, who are the main actors,
where are decisions made, and how evidence fits into
the process.
The structure of this paper is as follows. First, drawing
on a dataset from a recent systematic review of barriers
and facilitators [30], we offer a high-level overview of
the literature on evidence use in health policy, drawing
out broad theoretical and definitional commitments.
This paper does not primarily consider the findings of
those studies, which are summarised above and set out
in more detail elsewhere [30]. We also draw on similar
findings about policymakers in non-health fields [35].
We set these data in the context of the wider theoretical
literature about evidence and policy, drawing insights
from policy sciences. Secondly, we aim to identify and
challenge some of the more normative assumptions
which are widely prevalent (if often implicit) in the
EBP literature, particularly the following: that the
policy-evidence ‘gap’ needs ‘bridging’; that policy is
usually not based on any data; that policy requires research
evidence, preferably evaluative intervention research
evidence; and that if more evidence were used in
Table 1 Comparing three systematic reviews on evidence-based policy
Orton, 2011 Innvær, 2002 Oliver, 2014
Aims To synthesise evidence about the
extent, types, process of evidence
use, and barriers and facilitators
Synthesise facilitators of and barriers
to the use of research evidence by
health policymakers
To update Innvær 2002 and identify new
evidence in this area
Inclusion criteria
and search date
Europe, Canada, Australia, and NZ
only, must explore “how research
evidence is used in decision-making
for public health”. Primary studies only
Interview studies with health policy
decision-makers responsible for
decisions on behalf of organisations
All studies reporting barriers or facilitators
of use of evidence, from 2002–2011
Types of studies
included
18 included, interviews and surveys 24 studies in 26 papers, interviews
and surveys
145 included studies: 13 systematic reviews,
42 interviews/qualitative studies, 13/25
entirely/included survey
Types of results
presented
PMs perceptions about the use
of evidence; qualitative and
closed-response
PMs perceptions about the use of
evidence; qualitative and closed-response.
Types of ‘use’, theories about evidence use
Perceived and observed factors affecting
evidence use; definitions of evidence;
theories used in included studies
Use of
evidence?
Self-reported use of evidence in
2 studies, undermined by quality
concerns
21/24 examined actual decision-making
processes, all measured perceptions of use
or hypothetical use of evidence
33 studies examine research uptake
(amount/rate), 50 examine processes of
research uptake, 18 examine the impact of
research use
Synthesis and
QA used
Narrative synthesis; CASP-based QA Descriptive synthesis; methodological QA Descriptive synthesis; no QA
Main facilitators Improved relationships; researchers
trained to disseminate, clear, relevant
and easy-access research; PM trained
in research skills; change of policy culture
Personal contact between researchers and
PMs; timeliness and relevance of research,
with clear recommendations and high
quality; research confirming current policy
Available, clear and relevant research
evidence; relationships, collaboration, and
contact between researchers and PMs;
timing, practical managerial support
Main barriers Unclear, irrelevant or low-quality
evidence. ‘Gulf’ between researchers
and policymakers. Lack of PM research
skills. Other pressures; practical constraints:
financial, time frames, access to research,
presentation, and interpretation
Absence of personal contact between
researchers and policymakers; lack of
timeliness or relevance; mutual mistrust
between scientists and policymakers
Power and budget struggles
lack of clear or relevant research evidence
and costs; lack of timeliness or opportunity;
lack of PM research skills or awareness
Theory None cited Weiss, Caplan; two-communities thesis Range of theories, reports which papers
used which theory
Conclusions and
implications
Action to address the barriers and
facilitators needs to be taken; training
to overcome barriers to research use;
research on interventions to increase
research uptake
Studies partially support common beliefs
about barriers and facilitators, with little
empirical evidence; no strong
recommendations about research and
policy can be made; limited data support
two-communities and Weiss’s theories
Research into managerial and
organizational barriers may be more
useful than individual-level; relational
approach could be used
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make suggestions for a new agenda for EBP research.
We are not advocating against EBP. On the con-
trary, we believe that better policy decisions would be
a desirable outcome, and that evidence ought to play
a role in those decisions. Rather, our conclusions
from this critical review of the literature are about
EBP research, rather than EBP itself. Researchers have
directed their attention at how to increase the impact
of their own outputs, rather than on understanding
the processes behind policy change. The support for
EBP is not as single-minded or vociferous as it was.
Reflecting on this historical trend, and reasons behind
any such shift, we present our novel contribution to
the literature: an illumination of the discourse around
EBP by comparing theories, methods, and substantive
approaches with those from other fields, and on this
basis propose new directions for EBP research.Review: evidence-based policy research
Below, we describe some of the underlying concepts and
approaches available to researchers attempting to under-
stand the relationship between research and policy
processes.
Theoretical underpinnings
Innvær et al. described how the literature at the time
fell into two camps [34]; those supporting the ‘two-
communities’ hypothesis, which explores whether barriers
to research utilisation are mainly driven by cultural
or institutional differences between researchers and
decision-makers, and those drawing on Carol Weiss’s
typology of ways of using evidence [36,37]. Policy and
academic actors were conceptualised as opposing sets of
actors, with different priorities, languages, practices, and
priorities. For proponents of this perspective, ‘bridging’
this gap becomes a priority. It seems likely, however, that
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previously neutral actors; and indeed this debate fails
to recognise that this may be a UK-specific problem
(cf. to Dutch studies).
Models of the research and policy processes are, as
noted by previous theorists of EBP, rarely made explicit
in evaluations of applied research. Where implicit, a
simple ‘pipeline’ model is usually assumed (i.e., that the
more research is carried out and the higher the quality,
the bigger the effect on policy and practice) [38-41].
A large new theoretical strand within health policy
focuses on knowledge brokerage/translation as a frame-
work for understanding use of evidence [42-46]. This
model can be seen as an extension of Weiss’s ‘instru-
mental use’ model, or ‘enlightening’ and ‘strategic use’ of
evidence, describing the influence of research on policy,
and is linked to ideas about ‘coproduction’ and ‘user in-
volvement’ [47].
Weiss and Caplan are still major influences on the
field of EBP research, but the degree to which these
contributions are appropriately exploited is debatable.
The linear (direct use) model is usually perceived to
be superior, quite contrary to Weiss’ argument that
policymakers thought enlightening (indirect) use could
offer more. This message is often overlooked by research
(and researchers) in the field, namely that researchers
need to reflect on the common view that policymakers are
interest-oriented and indifferent to evidence. Barriers to
use of research are equated with barriers to direct use
of research, while the broader concept of enlightening
(indirect) use is rarely seen as equally relevant and useful.
While this is still widespread, theoretical learning from
other fields is filtering into the debate. Researchers in
policy studies have long seen the policy process itself as
a contested arena of negotiation [48,49]. The messy,
complex, and serendipitous nature of policymaking is
described by Kingdon [50], Weiss [51], Simon [52], and
Lindblom [53], amongst others. These scholars have
contributed ideas such as punctuated equilibrium [54],
policy ‘windows’ and ‘streams’ [50] or ‘stages’ [48], bounded
rationality [55], and incrementalism [53]. However, the
degree to which these models are used in planning and
conducting empirical research is debateable. As Lomas
notes, one reason why these may have been resisted by
EBP researchers is because they offer little help and no
tools to help the aspiring policy-advisor [56].
Of course, many of these are theories about policy,
rather than analysis tools to assist advisors [57]. Cairney
argues that policy analysts tend to use concepts, such as
the policy cycle, which have been rejected by policy
scholars. We would qualify this statement by restricting the
rejection of such theories to within science and technology
studies and policy sciences – these ideas are still common
currency within health policy amongst other fields [58].The influence of these ideas on the health field is
perhaps increasing, with applications of ethnographic
methods [59] and actor-network theory applied to
EBP [60]. However, the majority of studies still use
over-simple theoretical models [61]. Asserting the existence
of and describing and prescribing interventions to close the
‘research-policy gap’ is a stance which, we argue, is likely to
perpetuate and even create gaps between the professions.
Focus of the research
The main focus of much theoretical and empirical work
in EBP has traditionally been, implicitly or explicitly, on
research evidence uptake, primarily peer-reviewed research
carried out by university-based academics [30,31]. However,
a third of studies included in our review examined non-
research data, for example, public health surveillance data,
strategic needs assessments and other impact assessments,
geographic information systems [62], or other non-research
evidence [63-65]. This suggests that policymakers interpret
and use ‘evidence’ in a broad sense, which is usually not
acknowledged by academic commentators [7,10].
The reviews described above included a minority of
studies which aimed to describe the policy process in
detail, often using a case-study approach. Frequently,
these focused on the use of a particular type of evidence
such as economic evaluations [66] or the role of a
specific piece of evidence [60,67]. Few attempt a descriptive
contextualisation or ethnographic understanding of the
policy process, with exceptions, e.g., [68-71]. Virginia
Berridge’s seminal work on the NHS and comparative
health policy development uses historical methods to
understand these processes and develop theory around
them [72]. Others have taken empirical ethnographic
approaches to understand, for instance, how health
decision-makers conceptualise and use evidence [73,74].
With these exceptions, very few studies have, as yet, taken
anthropological or historical approaches to understanding
the role of evidence or research in policy.
Research in the area thus focuses primarily on how to
increase uptake of research, on designing and evaluating
interventions aiming to increase research use, and on
identifying barriers and facilitators of research use by
policymakers [74-76]. This pattern of research on
evidence use skews the debate by focusing on exceptional
cases of research use in policy-making, rather than the
normal discharging of statutory business. As Kogan and
Henkel noted, attempts to improve use of evidence can
“fail to note how in those areas of policy where data are
diffuse, and analyses most likely to be strongly influenced
by value preferences, problems must be identified
collaboratively between policy-maker and scientist. It
failed to acknowledge that policy makers have to work
hard to identify problems, to specify research that
might help solve them, and to receive and use the results
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Rothschild experiment, the suggestion that EBP research
does not reflect the range of knowledge-producing or
policy-making processes can also be levied at much of the
academic work subsequent to this important study.
Focusing on the use of research evidence also allows
researchers to sidestep the rest of the policy process and
avoid the context of decision-making more widely. Most
studies focus on single elements of the policy-making
process – dissemination of evidence, sources, and types
of source, knowledge transfer, and priority setting – rather
than trying to characterise the process as a whole. EBP
research could draw here on an extensive research
literature in policy analysis from political science,
starting with studies of what is called ‘the policy cycle’ or
‘a stages approach’ [39,77]. Such studies can analyse who
is making which decisions, about what, and when; the
distinction between practice, management, governance,
and policy is rarely spelt out [78]. Clear definitions of
policy, use of research, and decision making has been
encouraged for over 60 years, but remains evasive [79].
Methods
Considerable theoretical work has gone into producing
taxonomies of factors influencing the utilisation of
evidence, e.g., [36,80]. However, these rich theoretical
discourses are not reflected in the bulk of the empirical
literature, which, despite its breadth with respect to the
sectors and categories of evidence types studied, finds
fairly consistently that the main factors affecting use of
evidence are (a) access to relevant and clear information
and (b) good relationships between researchers and research
users. This may be due to the methods used in the
studies: most use only interviews or surveys to ask
researchers and policy-makers about their perceptions
about evidence use; very few use methods such as
participant observation to observe how evidence is
actually used in practice, or attempt to find documen-
tary proof of research use (with exceptions; [76]).
These lists, while important, cannot on their own lead
us to an improved understanding of the role of evidence
in the jigsaw of the policy process.
Another noticeable feature of the evidence base is the
emphasis given to researchers’ own views of research util-
isation, for example, a study aiming to look at everyday
working practice, such as that of Taylor-Robinson et al.
[81], samples primarily health inequalities/public health
academics and practitioners rather than decision-
makers themselves (such as councillors or executives), even
though they themselves describe lack of contact between
academics and policymakers as a barrier to use of evidence.
The majority of academic studies in EBP research are,
unsurprisingly, written by and for academics, with
little involvement of policy-makers as co-authors; indicatingthat policy-makers are not involved in developing or
carrying out relevant research.
Underlying assumptions of this research and
critical reflections
This overview of the literature provides a starting point for
a more critical engagement with the empirical literature on
EBP. We provide a broad-brush characterisation of parts
of the literature which helps to draw out common
assumptions across the field as a whole and enable
critical reflection on them. We focus on three such
assumptions: 1) that the policy-evidence ‘gap’ needs
‘bridging’; 2) that policy is usually not based on any
data, and policy requires research evidence, preferably
evaluative intervention research; and 3) that greater
use of evidence in policy-making will produce better
outcomes at a population level. It is by no means the case
that these assumptions are universally shared among EBP
researchers, or that we are the first to identify these issues
[61,82,83]. Nonetheless, a large proportion of the available
research still rests on an uncritical acceptance of these
assumptions. Below, we describe the effect of these
assumptions, justify our rejection of them, and discuss the
implications of taking a more critical approach.
Assumption 1: that a policy-evidence ‘gap’ exists
The ‘evidence-policy gap’ is a widely-acknowledged
construction in policy-related research, asserting the
existence of two separate communities with their own
ecosystems and languages [61,83-85]. Much of the
‘knowledge translation’ literature, which attempts to
take a broader perspective on EBP, fails to question
the assumption that knowledge and practice are two
separate practices, and the ‘joining’ or ‘bridging’ of
these (depending on the authors’ preferred metaphor) is
the task of EBP researchers; see, e.g., [20,61,83,84,86].
However, as Choi recognizes, evidence – and those
associated with evidence – is just one voice among many
[87]. We do not yet know how to make that voice more
helpful nor more influential.
Recently, a shift away from this dichotomous debate has
been made, with concepts such as ‘knowledge translation’
or ‘transfer’ being replaced by ideas about ‘learning’,
‘contribution’, and co-production [88]. These ideas
frame the relationship between research and policy as
a two-way negotiation in which both partners learn
from the other – pragmatically and politically a step
towards an equality of prioritisation and experience.
Certainly, this represents a greater openness to seeing
a broader range of data types as relevant – including,
for example, contextual, descriptive data as well as
evaluations and other forms of research evidence. Too
often, however, this debate is hijacked by methodologists
from opposing camps wishing to defend their own
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e.g., [89,90]. Without clear definitions of ‘evidence’ and
‘impact’ or ‘learning’, these studies contribute to negative
stereotypes on both sides, and perpetuate the gap they aim
to bridge.
Assumption 2: that policy is usually not based on
evidence
Despite the increased literature in the area, there is a
surprising lack of evidence about how much evidence
policymakers use. Studies have largely reported policy-
makers’ perceptions of their usage (e.g., [91]), acknowledge
that it is impossible to tell how much evidence was used by
policy participants [92], or rely on self-reported measures
[93]. EBP researchers have tended to interpret this absence
of any contradictory evidence as a confirmation of their
belief that policymakers do not use evidence. This is both
grossly unfair to policymakers who have been shown to
draw on a wide range of information sources [39], hugely
over-simplifies the relationship between evidence and
policy, and, of course, contradicts the avowed principles of
EBP researchers; viz, that beliefs ought to be based
on evidence [76].
Implicit in the ‘barriers and facilitators’ approach is an
assumption that if these factors were alleviated, research
uptake would increase. However, this is to miss the key
point, which is that most research in the area studies the
use of research evidence by policymakers, not what
knowledge or information policymakers use. This subtle
shift in emphasis opens up new avenues of enquiry.
Other information than research evidence might be more
relevant and timely, two factors seen as top facilitators for
policymakers’ use of evidence [94]. Policymakers may
prefer to use local information or intelligence such as
patient or practice level data, or that held by local councils
(e.g., datasets of rent, crime, and transport) [95]. It
seems likely that these sources of information have
been undervalued by evaluation methodologists, who often
value trial data above other types. A more naturalistic
approach using empirical methods to study policymakers
in vivo, would conceive of evidence as one of many
influences on a decision.
Assumption 3: that use of more research evidence
by policymakers would lead to ‘better’ policy
We are not the first to note that “[t]he assumption that
the use of evidence would improve the outcome of the
policy process remains relatively untested by any form of
empirical analysis” [96-98]. The absence of robust evalu-
ation evidence showing that evidence utilisation actually
leads to better outcomes is widely admitted. The bulk of
the intervention evidence in EBP uses only research
utilisation or uptake as an outcome (or, in some cases,
merely attitudes and intentions regarding research use).Nonetheless, it is still widely claimed that decisions made
in partnership between “politicians and researchers & lay
people are more likely to result in positive health outcomes”
[86] and many researchers continue to advocate for
increased use of research evidence [99].
Such claims, where they are not treated as automatically
self-evident, are usually supported either by anecdotal cases
of increased evidence use leading to better outcomes, or by
studies of the impacts of evidence use on process measures
such as transparency of decision-making [100]. However,
the value of process-oriented goals is surely questionable, if
they cannot be shown to lead to improved health,
wellbeing, social, or other outcomes for the putative
beneficiaries of the policy in question. The typologies
of ‘research impact’ which have dominated much work in
this area (e.g., [101]) are of limited value without a more
open debate about the correct metrics for evaluating EBP,
based on a realistic view of the currently existing evidence
base [102]. Moreover, much of the commentary around
the ‘impact agenda’ focuses on the aspect of academic
performance management, without wider examination
of its connection to policy and knowledge practices
and theories [16].
Even in the absence of robust evaluation data, it is
clear that many of the existing theoretical rationales for
how evidence utilisation is supposed to improve outcomes
are inadequate. If the pipeline model of research use were
correct, it would be possible to demonstrate the impact of
research on policy and the value of research would be
judged on its contribution to policy and its quantifiable
impact [25]. This model “fails the practitioner because the
literature on which guidelines are based constitutes an
unrepresentative sample of the varied circumstances and
populations in which the intervention might be usable or
unusable” [38].
New directions for EBP research
Above, we describe three assumptions commonly found
in the EBP literature. We critically discuss the reasons
we believe these assumptions are flawed, and show how
the existing research conducted on the basis of these
assumptions is likely to fail to answer the most pressing
problems in EBP. Here, we describe how these assumptions
can form the basis for a new programme of research aiming
to understand the relationship between science and policy.
We explore the implications of re-framing future studies in
a new direction, and suggest more explorative perspectives
and participative methods.
Firstly, the assumption that the policy-evidence ‘gap’
needs ‘bridging’. Most of the studies identified perpetuate
the division between the ‘two communities’ in one way or
another. Approaching researchers and policy-makers
separately and asking them for their accounts of evidence
use may be likely to produce these conflicting accounts;
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what policy-makers do may not be the most sensitive
way of exploring policy processes. It would be more
interesting, and more novel, to approach policymakers
from an unprejudiced stance, to describe their activities,
and to identify how they populate policy areas and steer
policies through [53]. Of course, we are not the first to
suggest this [56,97] – but these studies are generally the
exception rather than the rule.
Secondly, the assumption is often held that policy
is usually not based on any data, and policy requires
research evidence, preferably evaluative intervention
research. By concerning themselves with questions
such as “how [can] the tension between scientific
rigour and timely relevance to policy-making be handled”
[103], EBP researchers often fail to acknowledge their
lack of knowledge about forms and models of the
impact and contributions of evidence to policy pro-
cesses, which can lead to the creation of unhelpful
straw men.
Finally, the unspoken corollary to both these assumptions
is that greater use of evidence in policy-making will
produce ‘better policy’ and better outcomes at a population
level. Leaving aside the question of what constitutes ‘better’
in a self-evidently political and therefore value-driven
terrain, for researchers to convincingly argue for the
increased use of evidence in policy making, they must be
able to demonstrate the benefits of doing so. The growth of
the ‘applied research’ sector claims to address this, but often
restricts output to vague and untested policy and research
recommendations, about which there is no evidence of
effectiveness [99]. If the effects of these policy and research
recommendations are not evaluated these could be
misguided at best [104].
Therefore, we argue that the following issues are of
outstanding importance and could form the basis for a
new agenda of EBP research:
1. Refocus research on influences on and processes of
policy rather than how to increase the amount of
evidence used. Researchers in political and policy
studies, anthropology and history of policy, and
science and technology studies have provided a
wealth of insights and rich empirical data on the
functioning (or otherwise) of the policy-making
process [13,53,56,68-70,88,105-108]. Understanding
the daily lives and activities of policy actors can bring
fresh insights into how ‘evidence’ is conceptualised,
the potential roles it may play, and how it fits with the
other drivers and triggers which affect policy [95,109].
Understanding the roles of exceptional individuals,
such as policy entrepreneurs, and networks in the
policy process is also recognised as a key research
area [3,110,111].Dialogue between these fields has not been very
extensive or productive so far, largely due to
scepticism on the part of policy scientists, e.g., [108],
and a lack of engagement with this body of theory
and empirical data, with recent exceptions [112,113].
To take only one example, policy researchers
observe that policies rarely have a consistent and
well-defined goal or aim; rather, “solutions become
joined to problems” in a provisional and largely
haphazard way, with the same policy taking on
different goals at different times or in different
contexts [50,114]. If this is the case, the question
of how researchers can evaluate whether or not the
policy has attained its goal, and use the results of
this evaluation to inform future policy development,
is largely moot.
2. Determine what information and evidence is
normally used as part of policy processes. As we
point out above, it is likely that the needs and
practices of policymakers are rarely the subject of
rigorous study, and are certainly more complex and
nuanced than can be captured in surveys. Using
‘research’ and ‘policy’ as one-size-fits-all concepts
underestimates the variety of activities and outputs
involved in each type of process. A legislative
manoeuvre is very different from a local tailoring of
licensing hours; applied health research aiming to
develop interventions about a specific condition is
worlds away from contemplative studies of models of
theories of change. Elucidation of the relationships
at both ends of the spectra ought to be a research
priority, in place of the dichotomising of activities
as ‘research’ or ‘policy’. Furthermore, attention to
context is vital; pressures faced by researchers and
policymakers in low- and middle-income countries
may be very different from those in Western settings.
Finally, as argued above, although similar barriers and
facilitators are often identified across policy settings
[35], there is variation of practices and processes
across policy areas. Analysis of these variations
would be a whole research agenda in itself. A subtler
interpretation of context, ‘policy’, and ‘research’ are
necessary to understand processes, influences and
impacts, and indeed to develop any meaningful
abstractions and generalisations – should these be
possible, which is by no means certain. A compromise
between the complexity of policy making and
development of useful frameworks needs to
be found.
3. These questions are likely to require a broader range
of methodologies than usually applied. Experimental,
ethnographic, and conceptual studies all need to be
applied to understand the impact of evidence on
policy and policy processes more generally. Novel
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psychosocial, or interpretive [115-117].
4. Develop conceptual clarity around and metrics to
evaluate ‘impact’ of research on policy and
populations. Without clear methods to understand
how policy works and how it changes in response to
information, it will be impossible for researchers to
know whether they have had an effect on policy.
Research usage could take many forms, from
agenda-setting, to provision of policy options, to
challenging debates, or refuting arguments. Impact
could therefore be a change in policy, consistency in
policy, changes in population level outcomes.
Measures proposed thus far tend to focus on
citations or mentions of work by policymakers. We
feel this addresses only a narrow aspect of potential
impacts, namely awareness of research, which may
not translate into action. Furthermore, this metric-led
approach tends to ignore the indirect means by
which research and evidence of all kinds fit into
policy – whether by sustaining the status quo, or by
leading to decisions for change. More attention to the
variety of impacts and effects leading from research
may help to develop this debate.
5. Finally, our analysis of the literature suggests that
new methods and organisations aiming to bring the
processes of research and policy closer together are
likely to further our understanding of the
relationship between these two types of activities.
Co-creation and co-production of knowledge are
lauded as a more democratic, and potentially more
useful, type of learning activity than many other
knowledge exchange events [118]. If universities
were to provide assistance for local policymakers in
the analysis of existing data, a relationship of mutual
benefit could start to develop – an end in itself,
according to reviews of barriers and facilitators of
evidence use [30,34]. Moreover, such organizations
would provide natural laboratories for studying the
role of institutional and organizational factors on the
practices of policy formation and implementation,
noted in our review as likely to affect evidence use.
Perhaps due to the political, financial, and ethical
pressures on health policymakers to make good decisions,
health policy leads the way in forming collaborative organi-
sations to conduct research. Funders in the UK and
Netherlands have developed specific types of collab-
orative engagement organisations (e.g., Collaborations
for Leadership in Applied Health Research and Care,
CLARHCs, or the health funder ZonMw), which aim to
bring practitioners and researchers together for mutual
benefit. There are examples of institutions which spe-
cifically allow researchers and policymakers to learnabout each other’s priorities and ways of working
[56,119]. In general, however, the literature above suggests
that there are insufficient opportunities and incentives to
form links with policymakers directly.
Conclusions
The existing literature on EBP has certainly contributed
to the desirable outcome of better policy decisions and
acceptance that evidence ought to play a role in those
decisions. Now, we believe it is time for researchers to
reflect on their assumptions, develop new perspectives,
and use other methods to tackle the problems of EBP.
There is a common lack of clarity about what researchers
understand as ‘policy’, which can encompass decision
making, project implementation and evaluation, and
service reconfiguration. There is, in general, little evidence
about management and organisation, despite these being
potentially major factors affecting the policy process [120].
The assumptions governing the design and outcomes of
research into policy will probably be significantly different
in different institutional areas. It is often not clear what
constitutes ‘a decision’, nor who is involved in it, or whether
research evidence is relevant or timely. This muddles and
prevents any engagement with discussions about what
constitutes good and bad policy; or indeed how evidence
ought to be used.
Rather than attempting to develop a one-size-fits-all
(pipeline) model, research in this area should revert to
observational methods with in-depth descriptions of
practices and their inherited processes and provide an
empirical basis for theoretical development which can
inform future activities. Instead of repeating studies of
perceptions of barriers and facilitators of use of research
evidence, appropriate methods must be used to answer
questions about when, why, how, and who finds what
type of knowledge sound, timely, and relevant at different
stages of the policy cycle.
The position of researchers who wish to influence
policy is untenable unless there is engagement with
the questions outlined above. We would also argue that
researchers who advocate for change (for example, via
policy and practice recommendations) without evaluating
the (likely) impact of these changes may have a limited
effect at best. At worst, they create distance between
policy and research by demonstrating an understanding
of the context within which they would like their newly-
generated knowledge to be used. Without understanding
the complex processes of policy and knowledge mobilisa-
tion, researchers who make policy and practice recom-
mendations may simply be ignored. Ultimately, the role of
researchers is not to judge the ‘quality’ of policy making
on the basis of how much of their research is used. This
stance is both unhelpful and divisive, blinding researchers
to the important questions raised above regarding the
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and under which circumstances. Rather, our role as
scientists ought to be to investigate the processes
surrounding the use of evidence and policy activities
more widely and to disseminate findings in order to
help others make informed decisions, of all kinds.
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